Immediate Impact
2 from Science/Nature 27 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Tiffany Richards being referenced
Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tiffany Richards | 84 | 150 | 64 | 116 | 27 | 311 | |
| Erin Stevens | 47 | 46 | 104 | 105 | 43 | 369 | |
| Frances M. Wiley | 54 | 91 | 50 | 74 | 13 | 364 | |
| Ashley Perry | 124 | 81 | 49 | 50 | 36 | 347 | |
| Chie Watanabe | 14 | 90 | 73 | 55 | 26 | 348 | |
| Jun‐ichi Azumi | 59 | 111 | 36 | 31 | 24 | 326 | |
| Mei Yoke Chan | 95 | 25 | 51 | 154 | 30 | 338 | |
| Lining Wang | 36 | 66 | 63 | 54 | 32 | 277 | |
| Morgan Similuk | 25 | 131 | 34 | 38 | 30 | 314 | |
| Joy M. Fulbright | 22 | 79 | 50 | 91 | 29 | 295 | |
| Bojana Brajenović‐Milić | 26 | 75 | 18 | 54 | 34 | 357 |
All Works
Loading papers...